Delivery Order SPE2DR25D6028-SPE2DR26FAUMS
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,894.19 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Xyosted 50 mg/0.5 ml auto-injector vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is expected to be fulfilled by January 7, 2026. AmerisourceBergen Drug Corp operates as the subsidiary of...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.59 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector prefilled syringes. The contract, which is a firm fixed-price delivery order without set-aside designation, was awarded on January 22, 2026, with an ultimate completion date of January 23, 2026. Performance will take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,871.34 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 17, 2025. The award was issued on October 16, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies, valued at $1,500.30 with an ultimate completion date of October 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,114.47 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injector units. This is a firm fixed price, competitively awarded contract with no set-aside designation, completed on May 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling the delivery order from its corporate office location in the same municipality. Xyosted...
- The Defense Logistics Agency awarded a $6,457.14 delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a $1,436.03 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector units. The contract is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.70 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was awarded on January 12, 2026. This award is a non-set-aside contract, competed on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.31 to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Xyosted 100 mg/0.5 mL auto-injector vials. The contract is structured as a firm fixed-price delivery order with a completion date of January 8, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis and represents a task order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.32 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 ml auto-injector units on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product used in the treatment of male...